# Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

> **NCT03296826** · — · RECRUITING · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 600 (estimated)

## Conditions studied

- BRCA1 and/or BRCA2 Variant Carriers
- Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Peritoneal Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03296826
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-11-08
- **Primary completion:** 2032-03-31
- **Final completion:** 2032-03-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296826, "Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03296826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*